Crohn disease is a chronic idiopathic inflammatory bowel disease condition characterized
by skip lesions and transmural inflammation that can affect the entire gastrointestinal tract …

Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract, with
increasing incidence worldwide. Crohn's disease might result from a complex interplay …

Ulcerative colitis (UC) is driven by disruptions in host–microbiota homoeostasis, but current
treatments exclusively target host inflammatory pathways. To understand how host …

There is a clinical need for new, more effective treatments for chronic and debilitating
inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. In this …

Six biologic agents are currently approved for the treatment of IBD: four anti-TNF agents
(infliximab, adalimumab, golimumab and certolizumab pegol) and two anti-integrin agents …

The Real-World Effectiveness and Safety of Vedolizumab for M... : Official journal of the American
College of Gastroenterology | ACG The Real-World Effectiveness and Safety of Vedolizumab for …

Inflammatory bowel disease (IBD) is a chronic recurrent intestinal disease and includes
Crohn's disease (CD) and ulcerative colitis (UC). Due to the complex etiology of colitis, the …

Abstract Background and Aims: The efficacy of azathioprine for Crohn's disease under
adalimumab treatment remains obscure. Methods: In an open-labelled prospective study …

Background Faecal microbiota transplantation is an experimental approach for the treatment
of patients with ulcerative colitis. Although there is growing evidence that faecal microbiota …

Risk of complications from specific classes of drugs for inflammatory bowel diseases (IBDs)
can be kept low by respecting contraindications. Patients with IBD frequently develop …